CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $447,000 | -1.5% | 87,723 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $454,000 | -14.3% | 71,723 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $530,000 | -16.1% | 68,533 | -29.0% | 0.00% | -33.3% |
| Q4 2020 | $632,000 | -5.2% | 96,549 | -3.7% | 0.00% | 0.0% |
| Q3 2020 | $667,000 | -16.7% | 100,234 | +4.2% | 0.00% | -25.0% |
| Q2 2020 | $801,000 | +169.7% | 96,164 | +148.7% | 0.00% | +100.0% |
| Q1 2020 | $297,000 | +175.0% | 38,664 | +284.4% | 0.00% | +100.0% |
| Q1 2019 | $108,000 | -65.5% | 10,057 | -51.5% | 0.00% | -50.0% |
| Q4 2018 | $313,000 | -19.3% | 20,737 | -1.0% | 0.00% | 0.0% |
| Q3 2018 | $388,000 | +3.2% | 20,952 | +27.5% | 0.00% | 0.0% |
| Q2 2018 | $376,000 | -17.4% | 16,432 | +2.7% | 0.00% | -33.3% |
| Q1 2018 | $455,000 | +31.5% | 16,002 | -2.4% | 0.00% | +50.0% |
| Q4 2017 | $346,000 | – | 16,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |